Eli Lilly Receivables 2010-2024 | LLY

Eli Lilly receivables for the quarter ending December 31, 2024 were $13.275B, a 17.11% increase year-over-year.

  • Eli Lilly receivables for 2024 were $13.275B, a 17.11% increase from 2023.
  • Eli Lilly receivables for 2023 were $11.336B, a 32.45% increase from 2022.
  • Eli Lilly receivables for 2022 were $8.559B, a 5.31% increase from 2021.

Eli Lilly Receivables 2010-2024 | LLY

  • Eli Lilly receivables for 2024 were $13.275B, a 17.11% increase from 2023.
  • Eli Lilly receivables for 2023 were $11.336B, a 32.45% increase from 2022.
  • Eli Lilly receivables for 2022 were $8.559B, a 5.31% increase from 2021.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B